Literature DB >> 20514110

[Methoxy polyethylene glycol-epoetin beta (Mircera) in the treatment of a patient with chronic kidney disease presenting late-onset hypersensitivity to other epoetins].

C L Dávila Fajardo, M Peña Ortega, J Cabeza Barrera, M D Prados Garrido.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514110     DOI: 10.3265/Nefrologia.pre2010.Mar.10310

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


× No keyword cloud information.
  2 in total

1.  Efficacy & safety of continuous erythropoietin receptor activator (CERA) in treating renal anaemia in diabetic patients with chronic kidney disease not on dialysis.

Authors:  Sameer G Vankar; Pinaki Dutta; H S Kohli; Anil Bhansali
Journal:  Indian J Med Res       Date:  2014-01       Impact factor: 2.375

2.  Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia.

Authors:  Neval Duman; Abdullah Uyanik; Abdulkadir Unsal; Siren Sezer; Taner Camsari; Mustafa Cirit; Mehmet Emin Yilmaz; Bülent Altun; Murat Duranay; Alaattin Yildiz; Idris Sahin; Ayhan Dogukan; Sedat Ustundag; Ibrahim Karayaylali; Arzu Kahveci; Sukru Sindel; Ahmet Alper Kiykim; Yavuz Yenicerioglu; Ertugrul Akbas; Fatih Ozdener
Journal:  Clin Kidney J       Date:  2014-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.